Decentralized trials help developers of central nervous system treatments and devices address shifting regulatory barriers.

While working for Hewlett-Packard’s medical group, a manager said, “When the barriers to entry are high, those who overcome them have a strategic advantage.” That adage has remained important in the ...

The Nuclear Regulatory Commission on May 29 cleared NuScale Power’s uprated small modular reactor for use in the United ...

In this Drug Digest episode, Abzena’s vice president of Regulatory Strategy, Jeff Mocny, and Cellares’ director of Regulatory Affairs, Anna McMahon, examine how evolving regulatory and quality ...

Join this webinar and engage in a conversation with the West Pharmaceutical Services team about a risk-based approach for combination products. By the end of the program, you can expect to have a ...

Now regulatory review teams have found a way to accelerate their processes — processes not particularly suited to speed — without compromising quality, accuracy, or adherence to regulations, how can ...

On 16 February 2022, Jane Halton argued that co-design, not secondments, is the key to enhancing the public services’ understanding of business. Increasingly, there is an expectation that regulatory ...

Brazil’s ECA Digital introduces a safety-by-design approach to protect minors online. It replaces ex post liability with ...